Overview
Internuclear ophthalmoplegia (INO) involving abduction highlights lesions within the brainstem affecting pathways between the paramedian pontine reticular formation and the ocular motor nuclei, specifically impairing phasic eye movements without affecting tonic muscle function 1.Diagnosis
Key Diagnostic Criteria: Slowed abduction saccades without limitation in end position, indicative of impaired phasic ocular motor activity 1.
Recommended Tests: Neuroimaging (MRI/CT) to identify brainstem lesions 1.
Grading: Clinical grading based on severity and extent of eye movement impairment 1.Management
First-Line Treatments: Address underlying cause (e.g., vascular, demyelinating) with specific interventions as indicated 1.
Adjunctive Treatments: No specific drug treatments mentioned for INO management 1.Special Populations
Pediatrics: No specific information provided 1.
Elderly: No specific considerations noted 1.
Comorbidities: Management should focus on treating underlying conditions contributing to brainstem lesions 1.Key Recommendations
Identify and treat the underlying cause of internuclear ophthalmoplegia to manage symptoms effectively (Evidence: Expert opinion 1).
Utilize neuroimaging (MRI/CT) for accurate localization of brainstem lesions contributing to ocular motor dysfunction (Evidence: Expert opinion 1).
Monitor and manage any comorbidities that may exacerbate brainstem pathology (Evidence: Expert opinion 1).References
1 Kommerell G. Internuclear ophthalmoplegia of abduction. Isolated impairment of phasic ocular motor activity in supranuclear lesions. Archives of ophthalmology (Chicago, Ill. : 1960) 1975. link